4.7 Article

Randomized phase 2 study of subcutaneous amifostine versus epoetin-α given 3 times weekly during concurrent chemotherapy and hyperfractionated radiotherapy for limited-disease small cell lung cancer

Related references

Note: Only part of the references are listed.
Article Oncology

A phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer

Pramila Rani Anne et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)

Article Oncology

Amifostine reduces side effects and improves complete response rate during radiotherapy: Results of a meta-analysis

AD Sasse et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)

Article Oncology

Randomized phase III trial of radiation treatment ± amifostine in patients with advanced-stage lung cancer

D Antonadou et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)